Skip to main navigation Skip to search Skip to main content

Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity

  • Joseph Rucker*
  • , Michel Samson
  • , Benjamin J. Doranz
  • , Frédérick Libert
  • , Joanne F. Berson
  • , Yanjie Yi
  • , Robert J. Smyth
  • , Ronald G. Collman
  • , Christopher C. Broder
  • , Gilbert Vassart
  • , Robert W. Doms
  • , Marc Parmentier
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

277 Scopus citations

Abstract

Macrophage-tropic (M-tropic) HIV-1 strains use the β-chemokine receptor CCR5, but not CCR2b, as a cofactor for membrane fusion and infection, while the dual-tropic strain 89.6 uses both. CCR5/2b chimeras and mutants were used to map regions of CCR5 important for cofactor function and specificity. M- tropic strains required either the amino-terminal domain or the first extracellular loop of CCR5. A CCR2b chimera containing the first 20 N- terminal residues of CCR5 supported M-tropic envelope protein fusion. Amino- terminal truncations of CCR5/CCR2b chimeras indicated that residues 2-5 are important for M-tropic viruses, while 89.6 is dependent on residues 6-9. The identification of multiple functionally important regions in CCR5, coupled with differences in how CCR5 is used by M- and dual-tropic viruses, suggests that interactions between HIV-1 and entry cofactors are conformationally complex.

Original languageEnglish
Pages (from-to)437-446
Number of pages10
JournalCell
Volume87
Issue number3
DOIs
StatePublished - 1 Nov 1996

Fingerprint

Dive into the research topics of 'Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity'. Together they form a unique fingerprint.

Cite this